Nanophytomedicine Market: Global Opportunity Analysis and Industry Forecast

Phytomedicines play a decisive role since prehistoric times. Now-a-days about 50% of drugs used in formulations are obtained from natural based sources. Phytomedicines demonstrate magnificent in vitro activity and less in vivo activity because of high lipophilicity, low water solubility, poor permeability, instability, high first pass metabolism, and undesirable molecular size. These biopharmaceutical issues are calculatedly responsible for poor systemic availability. India is the second largest exporter of phytomedicine across the globe. India is second to China in this ranking, with 6600 medicinal plants. India produces over 70% of the phytomedicine claim throughout the world. Indian traditional system of medicine constituted of systems such as Ayurveda, Unani, Siddha, Yoga, Homeopathy, Naturopathy. In this book chapter authors thoroughly done literature review of the current trend of phytomedicine with special emphasis on nanomedicine in India as well as global levels.